{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:54:55Z","timestamp":1774976095974,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"TETFUND NRF","award":["NRF2021_SETI_HSW_00478"],"award-info":[{"award-number":["NRF2021_SETI_HSW_00478"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-89989-9","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T10:34:30Z","timestamp":1755686070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In-silico screening of small compounds against Lassa fever haemorrhagic virus nucleoprotein"],"prefix":"10.1038","volume":"15","author":[{"given":"Ekpo Eyo","family":"Antai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwem Okon","family":"Edet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth N.","family":"Mbim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ini Ubi","family":"Bassey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-9967","authenticated-orcid":false,"given":"Sozan M.","family":"Abdelkhalig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca O.","family":"Nwaokorie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1076-9740","authenticated-orcid":false,"given":"Ehssan","family":"Moglad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamda","family":"Ponmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Al-Shouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawsan","family":"AlShouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Destiny E.","family":"Charlie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohnad","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"4","key":"89989_CR1","doi-asserted-by":"publisher","first-page":"670","DOI":"10.4269\/ajtmh.1970.19.670","volume":"19","author":"JD Frame","year":"1970","unstructured":"Frame, J. D., Baldwin, J. M. Jr, Gocke, D. J. & Troup, J. M. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am. J. Trop. Med. Hyg. 19(4), 670\u2013676. https:\/\/doi.org\/10.4269\/ajtmh.1970.19.670 (1970).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"10","key":"89989_CR2","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3390\/v4102031","volume":"4","author":"NE Yun","year":"2012","unstructured":"Yun, N. E. & Walker, D. H. Pathogenesis of Lassa fever. Viruses 4(10), 2031\u20132048. https:\/\/doi.org\/10.3390\/v4102031 (2012).","journal-title":"Viruses"},{"key":"89989_CR3","unstructured":"WHO. Lassa fever\u2014Nigeria. (2023, accessed 30 Apr 2024). https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON463."},{"key":"89989_CR4","unstructured":"NCDC. Lassa fever situation report. Epidemiology. Week 7 2024. (2024, accessed 26 Apr 2024). https:\/\/ncdc.gov.ng\/themes\/common\/files\/sitreps\/3702b20687cb7bea4834b4a2db1a13ac.pdf."},{"issue":"1","key":"89989_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/v15010146","volume":"15","author":"C Aloke","year":"2023","unstructured":"Aloke, C. et al. Combating Lassa Fever in West African Sub-region: progress, challenges, and future perspectives. Viruses 15(1), 146. https:\/\/doi.org\/10.3390\/v15010146 (2023).","journal-title":"Viruses"},{"issue":"4147","key":"89989_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.185.4147.263","volume":"185","author":"TP Monath","year":"1974","unstructured":"Monath, T. P., Newhouse, V. F., Kemp, G. E., Setzer, H. W. & Cacciapuoti, A. Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science 185(4147), 263\u2013265 (1974).","journal-title":"Science"},{"key":"89989_CR7","unstructured":"NCDC. NCDC Lassa fever outbreak weekly Situation Report No. 46\u2013December 1, 2017. (2017, accessed 28 Apr 2024). https:\/\/ncdc.gov.ng\/themes\/common\/files\/sitreps\/f4e54bdfa7457b4f3cdac28d93712a3c.pdf."},{"key":"89989_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.14202\/IJOH.2020.95-98","volume":"6","author":"T Tewogbola","year":"2020","unstructured":"Tewogbola, T. & Aung, N. Lassa fever: history, causes, effects, and reduction strategies. Int. J. One Health. 6, 95\u201398 (2020).","journal-title":"Int. J. One Health"},{"key":"89989_CR9","unstructured":"WHO. Lassa fever.  (2017, accessed 31 Apr 2024). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/lassa-fever."},{"issue":"2 Suppl","key":"89989_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.21010\/Ajid.v16i2S.6","volume":"16","author":"AB Isaac","year":"2022","unstructured":"Isaac, A. B. et al. Prospects of lassa fever candidate vaccines. Afr. J. Infect. Dis. 16(2 Suppl), 46\u201358. https:\/\/doi.org\/10.21010\/Ajid.v16i2S.6 (2022).","journal-title":"Afr. J. Infect. Dis."},{"key":"89989_CR11","doi-asserted-by":"crossref","unstructured":"Tschismarov, R. et al. Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial. The Lancet 401(10384), 1267\u20131276 (2023).","DOI":"10.1016\/S0140-6736(23)00048-X"},{"key":"89989_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/JMDH.S347669","volume":"15","author":"M Sallam","year":"2022","unstructured":"Sallam, M., Al-Sanafi, M. & Sallam, M. AA global map of COVID-19 vaccine acceptance rates per Country: an updated concise narrative review. J. Multidiscipl. Healthc. 15, 21\u201345. https:\/\/doi.org\/10.2147\/JMDH.S347669 (2022).","journal-title":"J. Multidiscipl. Healthc."},{"key":"89989_CR13","doi-asserted-by":"publisher","first-page":"2333794X2110487","DOI":"10.1177\/2333794X211048738","volume":"8","author":"AD Wake","year":"2021","unstructured":"Wake, A. D. The acceptance rate toward COVID-19 vaccine in Africa: a systematic review and meta-analysis. Glob. Pediatr. Health. 8, 2333794X211048738. https:\/\/doi.org\/10.1177\/2333794X211048738 (2021).","journal-title":"Glob. Pediatr. Health"},{"key":"89989_CR14","doi-asserted-by":"crossref","unstructured":"Eyo, A. E. et al. Geometry optimization, impact of solvation on the spectral (FT-IR, UV,NMR) analysis, quantum chemical parameters, and the bioactivity of feruloyltyramine as a potential anti-Lassa virus agent via molecular docking. Chemi. Phys. Impact  7, 100338  (2023).","DOI":"10.1016\/j.chphi.2023.100338"},{"key":"89989_CR15","doi-asserted-by":"crossref","unstructured":"Odey, M. O. et al. Unraveling the impact of polar solvation on the molecular geometry, spectroscopy (FT-IR, UV, NMR), reactivity (ELF, NBO, HOMO-LUMO) and antiviral inhibitory potential of Cissampeline by molecular docking approach. Chem. Phys. Impact 7, 100346 (2023).","DOI":"10.1016\/j.chphi.2023.100346"},{"key":"89989_CR16","doi-asserted-by":"crossref","unstructured":"Kechi, E. L. et al.  X-ray crystallography, molecular structure investigation,Quantum chemical studies, and molecular dynamic of rheosmin as inhibitors of hemorrhagic Lassa Virus. J. Mol. Struct. 2023, 136048 (2023).","DOI":"10.1016\/j.molstruc.2023.136048"},{"key":"89989_CR17","doi-asserted-by":"publisher","first-page":"1206872","DOI":"10.3389\/fmicb.2023.1206872","volume":"14","author":"S Akash","year":"2023","unstructured":"Akash, S. et al. Development of a new drug candidate for the inhibition of Lassa virus glycoprotein and nucleoprotein by modification of evodiamine as promising therapeutic agents. Front. Microbiol. 14, 1206872. https:\/\/doi.org\/10.3389\/fmicb.2023.1206872 (2023).","journal-title":"Front. Microbiol."},{"key":"89989_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.fitote.2015.07.019","volume":"106","author":"K Gavaraskar","year":"2015","unstructured":"Gavaraskar, K., Dhulap, S. & Hirwani, R. R. Therapeutic and cosmetic applications of evodiamine and its derivatives\u2014a patent review. Fitoterapia 106, 22\u201335. https:\/\/doi.org\/10.1016\/j.fitote.2015.07.019 (2015).","journal-title":"Fitoterapia"},{"key":"89989_CR19","unstructured":"National Center for Biotechnology Information. PubChem Compound Summary for CID 45375808, Sofosbuvir. (2024, accessed 1 Mar 2024).  https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Sofosbuvir."},{"key":"89989_CR20","unstructured":"National Center for Biotechnology Information. PubChem Compound Summary for CID 49804500.  (2024, accessed 1 Mar 2024). https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/49804500."},{"issue":"19","key":"89989_CR21","doi-asserted-by":"publisher","first-page":"11513","DOI":"10.3390\/ijms231911513","volume":"23","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Evodiamine and Rutaecarpine as potential anticancer compounds: a combined computational study. Int. J. Mol. Sci. 23(19), 11513. https:\/\/doi.org\/10.3390\/ijms231911513 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"89989_CR22","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1177\/0963689719881366","volume":"28","author":"M Matsue","year":"2019","unstructured":"Matsue, M. et al. Measuring the antimicrobial activity of Lauric Acid against various Bacteria in human gut microbiota using a New Method. Cell Transplant. 28(12), 1528\u20131541. https:\/\/doi.org\/10.1177\/0963689719881366 (2019).","journal-title":"Cell Transplant."},{"issue":"7325","key":"89989_CR23","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/nature09605","volume":"468","author":"X Qi","year":"2010","unstructured":"Qi, X. et al. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 468(7325), 779\u2013783. https:\/\/doi.org\/10.1038\/nature09605 (2010).","journal-title":"Nature"},{"key":"89989_CR24","doi-asserted-by":"crossref","unstructured":"Zielesny, A. Chemistry Software Package ChemOffice Ultra 2005 (2005).","DOI":"10.1021\/ci050273j"},{"issue":"12","key":"89989_CR25","first-page":"1934578X2211430","volume":"17","author":"A Belal","year":"2022","unstructured":"Belal, A. et al. Toward the discovery of SARS-CoV-2 main protease inhibitors: exploring therapeutic potentials of evodiamine and its derivatives, virtual screening, molecular docking, and molecular dynamic studies. Nat. Prod. Commun. 17(12), 1934578X221143082 (2022).","journal-title":"Nat. Prod. Commun."},{"key":"89989_CR26","unstructured":"Jejurikar, B. L. & Rohane, S. H. Drug designing in discovery studio (2021)."},{"issue":"18","key":"89989_CR27","doi-asserted-by":"publisher","first-page":"9103","DOI":"10.1080\/07391102.2022.2140201","volume":"41","author":"B Kubra","year":"2023","unstructured":"Kubra, B. et al. Inhibition of the predicted allosteric site of the SARS-CoV-2 main protease through flavonoids. J. Biomol. Struct. Dyn. 41(18), 9103\u20139120 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"18","key":"89989_CR28","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1093\/bioinformatics\/btt399","volume":"29","author":"W Huang","year":"2013","unstructured":"Huang, W. et al. Allosite: a method for predicting allosteric sites. Bioinf. (Oxford Engl.)  29(18), 2357\u20132359. https:\/\/doi.org\/10.1093\/bioinformatics\/btt399 (2013).","journal-title":"Bioinf. (Oxford Engl.)"},{"key":"89989_CR29","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.84200","author":"A Stefaniu","year":"2019","unstructured":"Stefaniu, A. Introductory chapter: molecular docking and molecular dynamics techniques to achieve rational drug design. IntechOpen https:\/\/doi.org\/10.5772\/intechopen.84200 (2019).","journal-title":"IntechOpen"},{"key":"89989_CR30","doi-asserted-by":"crossref","unstructured":"Sarma, M., Borkotoky, S. & Dubey, V. K. Structure-based drug designing against Leishmania donovani using docking and molecular dynamics simulation studies: exploring glutathione synthetase as a drug target. J. Biomol. Struct. Dynamics 2023, 1\u20139. (2023).","DOI":"10.1080\/07391102.2023.2240429"},{"issue":"2","key":"89989_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2009","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31(2), 455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334 (2009).","journal-title":"J. Comput. Chem."},{"issue":"5","key":"89989_CR32","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.drudis.2021.12.017","volume":"27","author":"N Ye","year":"2022","unstructured":"Ye, N., Yang, Z. & Liu, Y. Applications of density functional theory in COVID-19 drug modeling. Drug Discovery Today. 27(5), 1411\u20131419. https:\/\/doi.org\/10.1016\/j.drudis.2021.12.017 (2022).","journal-title":"Drug Discovery Today"},{"key":"89989_CR33","unstructured":"Hiscocks, J. & Frisch, M. J.  Gaussian 09: IOps Reference (eds. Caricato, M. & Frisch, M. J.) (Gaussian, 2009)."},{"issue":"1\u20133","key":"89989_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46(1\u20133), 3\u201326. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0 (2001).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"89989_CR35","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires, D. E., Blundell, T. L. & Ascher, D. B. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58(9), 4066\u20134072 (2015).","journal-title":"J. Med. Chem."},{"key":"89989_CR36","doi-asserted-by":"crossref","unstructured":"Mboto, C. I. et al.  In-silico evaluation of bioactive compounds from selected medicinal plants from Southern Nigeria against hepatitis C virus genotype 1 RNA-directed RNA polymerase. Sci. Afr. 22, e01919 (2023).","DOI":"10.1016\/j.sciaf.2023.e01919"},{"issue":"8","key":"89989_CR37","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3390\/molecules23081899","volume":"23","author":"T Pantsar","year":"2018","unstructured":"Pantsar, T. & Poso, A. Binding affinity via docking: fact and fiction. Mol. (Basel Switzerl.) 23(8), 1899. https:\/\/doi.org\/10.3390\/molecules23081899 (2018).","journal-title":"Mol. (Basel Switzerl.)"},{"issue":"5","key":"89989_CR38","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3390\/molecules23051038","volume":"23","author":"D Ram\u00edrez","year":"2018","unstructured":"Ram\u00edrez, D. & Caballero, J. IIs it reliable to take the molecular docking top scoring position as the best solution without considering available structural data? Mol. (Basel Switzerl.) 23(5), 1038. https:\/\/doi.org\/10.3390\/molecules23051038 (2018).","journal-title":"Mol. (Basel Switzerl.)"},{"key":"89989_CR39","doi-asserted-by":"publisher","first-page":"131296","DOI":"10.1016\/j.molstruc.2021.131296","volume":"1247","author":"H ur Rashid","year":"2022","unstructured":"ur Rashid, H. et al. Molecular docking and dynamic simulations of Cefixime, Etoposide and Nebrodenside a against the pathogenic proteins of SARS-CoV-2. J. Mol. Struct. 1247, 131296 (2022).","journal-title":"J. Mol. Struct."},{"issue":"8","key":"89989_CR40","doi-asserted-by":"publisher","first-page":"e0268269","DOI":"10.1371\/journal.pone.0268269","volume":"17","author":"AJ Owoloye","year":"2022","unstructured":"Owoloye, A. J. et al. Molecular docking, simulation and binding free energy analysis of small molecules as pf HT1 inhibitors. Plos One 17(8), e0268269 (2022).","journal-title":"Plos One"},{"issue":"20","key":"89989_CR41","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.3390\/molecules27207009","volume":"27","author":"Q Sun","year":"2022","unstructured":"Sun, Q. The hydrophobic effects: our current understanding. Molecules 27(20), 7009 (2022).","journal-title":"Molecules"},{"issue":"5\u20136","key":"89989_CR42","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.bbapap.2018.03.002","volume":"1866","author":"S Basu","year":"2018","unstructured":"Basu, S. & Biswas, P. Salt-bridge dynamics in intrinsically disordered proteins: a trade-off between electrostatic interactions and structural flexibility. Biochim.  Biophys. Acta (BBA)-Proteins Proteom. 1866(5\u20136), 624\u2013641 (2018).","journal-title":"Biochim. Biophys. Acta (BBA)-Proteins Proteom."},{"issue":"7","key":"89989_CR43","doi-asserted-by":"publisher","first-page":"6311","DOI":"10.3390\/ijms24076311","volume":"24","author":"A Madushanka","year":"2023","unstructured":"Madushanka, A., Moura, R. T. Jr., Verma, N. & Kraka, E. Quantum mechanical assessment of protein\u2013ligand hydrogen bond strength patterns: insights from semiempirical tight-binding and local vibrational mode theory. Int. J. Mol. Sci. 24(7), 6311. https:\/\/doi.org\/10.3390\/ijms24076311 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"89989_CR44","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.3390\/ijms23031771","volume":"23","author":"S Rampogu","year":"2022","unstructured":"Rampogu, S., Lee, G., Park, J. S., Lee, K. W. & Kim, M. O. Molecular docking and molecular dynamics simulations discover curcumin analogue as a plausible dual inhibitor for SARS-CoV-2. Int. J. Mol. Sci. 23(3), 1771. https:\/\/doi.org\/10.3390\/ijms23031771 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"89989_CR45","doi-asserted-by":"publisher","first-page":"626363","DOI":"10.3389\/fmolb.2020.626363","volume":"7","author":"C Savojardo","year":"2021","unstructured":"Savojardo, C., Manfredi, M., Martelli, P. L. & Casadio, R. Solvent accessibility of residues undergoing pathogenic variations in humans: from protein structures to protein sequences. Front. Mol. Biosci. 7, 626363 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"89989_CR46","doi-asserted-by":"crossref","unstructured":"Ugbe, F. A. et al. Cheminformatics-based discovery of new organoselenium compounds with potential for the treatment of cutaneous and visceral leishmaniasis. J. Biomol. Struct. Dyn. 2023, 1\u201324 (2023).","DOI":"10.1080\/07391102.2023.2279269"},{"key":"89989_CR47","unstructured":"Akash, S. et al. Novel computational and drug design strategies for the inhibition of human T-cell leukemia virus 1-associated lymphoma by Astilbin derivatives. J. Biomol. Struct. Dyn.  2023, 1\u201316 (2023)."},{"key":"89989_CR48","doi-asserted-by":"crossref","unstructured":"Nwaokorie, F. et al.  In-silico assessment of bioactive compounds from chewing stick(Salvadora persica) against N-acetylneuraminate lyase (5ZKA) of Fusobacterium nucleatum involved in salicyclic acid metabolism. J. Mol. Struct. 1316, 138733 (2024).","DOI":"10.1016\/j.molstruc.2024.138733"},{"issue":"2","key":"89989_CR49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.drudis.2016.11.001","volume":"22","author":"A Ganesan","year":"2017","unstructured":"Ganesan, A., Coote, M. L. & Barakat, K. Molecular dynamics-driven drug discovery: leaping forward with confidence. Drug Discov. Today 22(2), 249\u2013269 (2017).","journal-title":"Drug Discov. Today"},{"issue":"5","key":"89989_CR50","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1080\/10406638.2022.2094420","volume":"43","author":"MG Babashkina","year":"2023","unstructured":"Babashkina, M. G., Taskin-Tok, T., Burkhanova, T. M. & Safin, D. A. 1-hydroxy-6, 6-Dimethyl-3-Phenyl-1, 6-Dihydropyridine-2, 5-Dione as a promising inhibitor of the SARS-CoV-2 proteins: insight into the crystal structure, Hirshfeld surface analysis and computational study. Polycycl. Aromat. Compd. 43(5), 4729\u20134749 (2023).","journal-title":"Polycycl. Aromat. Compd."},{"issue":"7","key":"89989_CR51","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/cryst13071020","volume":"13","author":"AH Bakheit","year":"2023","unstructured":"Bakheit, A. H., Attwa, M. W., Kadi, A. A., Ghabbour, H. A. & Alkahtani, H. M. Exploring the chemical reactivity, molecular docking, molecular dynamic simulation and ADMET properties of a tetrahydrothienopyridine derivative using computational methods. Crystals 13(7), 1020 (2023).","journal-title":"Crystals"},{"issue":"1","key":"89989_CR52","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1039\/c8md00472b","volume":"10","author":"L Guan","year":"2018","unstructured":"Guan, L. et al. ADMET-score\u2014a comprehensive scoring function for evaluation of chemical drug-likeness. MedChemComm 10(1), 148\u2013157. https:\/\/doi.org\/10.1039\/c8md00472b (2018).","journal-title":"MedChemComm"},{"key":"89989_CR53","doi-asserted-by":"publisher","first-page":"708364","DOI":"10.3389\/fchem.2021.708364","volume":"9","author":"N Flores-Holgu\u00edn","year":"2021","unstructured":"Flores-Holgu\u00edn, N., Frau, J. & Glossman-Mitnik, D. In silico pharmacokinetics, ADMET study and conceptual DFT analysis of two plant cyclopeptides isolated from rosaceae as a computational Peptidology approach. Front. Chem. 9, 708364 (2021).","journal-title":"Front. Chem."},{"key":"89989_CR54","doi-asserted-by":"crossref","unstructured":"Herdiana, Y., Wathoni, N., Shamsuddin, S. & Muchtaridi, M. Drug release study of the chitosan-based nanoparticles. Heliyon 8, 1 (2022).","DOI":"10.1016\/j.heliyon.2021.e08674"},{"key":"89989_CR55","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.2147\/IJN.S459510","volume":"19","author":"L Lin","year":"2024","unstructured":"Lin, L. et al. Evodiamine: a extremely potential drug development candidate of alkaloids from Evodia rutaecarpa. Int. J. Nanomed. 19, 9843\u20139870. https:\/\/doi.org\/10.2147\/IJN.S459510 (2024).","journal-title":"Int. J. Nanomed."},{"issue":"11","key":"89989_CR56","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.3390\/ijms19113403","volume":"19","author":"X Hu","year":"2018","unstructured":"Hu, X. et al. Antiproliferative effects of alkaloid evodiamine and its derivatives. Int. J. Mol. Sci. 19(11), 3403. https:\/\/doi.org\/10.3390\/ijms19113403 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"89989_CR57","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.3390\/molecules26113374","volume":"26","author":"S Bhambhani","year":"2021","unstructured":"Bhambhani, S., Kondhare, K. R. & Giri, A. P. Diversity in chemical structures and biological properties of plant alkaloids.  Mol. (Basel Switzerl.) 26(11), 3374. https:\/\/doi.org\/10.3390\/molecules26113374 (2021).","journal-title":"Mol. (Basel Switzerl.)"},{"key":"89989_CR58","doi-asserted-by":"crossref","unstructured":"Yamin, R. et al. Identifying plant-derived antiviral alkaloids as dual inhibitors of SARS- CoV-2 main protease and spike glycoprotein through computational screening. Front. Pharmacol. 15, 1369659 (2024).","DOI":"10.3389\/fphar.2024.1369659"},{"issue":"5","key":"89989_CR59","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/cben.202100050","volume":"9","author":"FO Nitbani","year":"2022","unstructured":"Nitbani, F. O., Tjitda, P. J. P., Nitti, F., Jumina, J. & Detha, A. I. R. Antimicrobial properties of lauric acid and monolaurin in virgin coconut oil: a review. ChemBioEng Rev. 9(5), 442\u2013461 (2022).","journal-title":"ChemBioEng Rev."},{"issue":"1","key":"89989_CR60","doi-asserted-by":"publisher","first-page":"23080","DOI":"10.1038\/s41598-023-49712-y","volume":"13","author":"A Alrehaily","year":"2023","unstructured":"Alrehaily, A., Elfiky, A. A., Ibrahim, I. M., Ibrahim, M. N. & Sonousi, A. Novel sofosbuvir derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective. Sci. Rep. 13(1), 23080. https:\/\/doi.org\/10.1038\/s41598-023-49712-y (2023).","journal-title":"Sci. Rep."},{"key":"89989_CR61","unstructured":"Radoshitzky, S. R., Buchmeier, M. J. & de la Torre, J. C. Fields virology. In Emerging Viruses, Vol. 1  (eds. Peter, M. H. et al.)   784\u2013809 (Wolters Kluwer\/Lippincott Williams & Wilkins, 2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89989-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89989-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89989-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:21:32Z","timestamp":1757478092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89989-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["89989"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-89989-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30558"}}